A novel membrane protein is a mouse mammary tumor virus receptor

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3066-3071

  Golovkina, Tatyana V ^a,c   Dzuris, John ^a   Van Den Hoogen, Bernadette ^a   Jaffe, Aron B ^a   Wright, Paul C ^b   Cofer, Shelagh M ^b   Ross, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

ALLELE; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CHROMOSOME 19; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONKEY; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ISOLATION; SEQUENCE HOMOLOGY; VIRUS ENVELOPE; VIRUS GENE; VIRUS INFECTIVITY;

EID: 0031950301     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3066-3071.1998     Document Type: Article

References (26)

1. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84: 8573-8577.
2. Beutner, U., E. Draus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.
3. Bolander, F. F., and M. E. Blackstone. 1991. Tissue distribution of the cellular binding protein for the mouse mammary tumor virus. J. Endocrinol. 7:169-174.
4. Dzuris, J. Unpublished data.
5. Dzuris, J., T. Golovkina, and S. R. Ross. 1997. Both T and B cells shed infectious mouse mammary tumor virus. J. Virol. 71:6044-6048.
6. Dzuris, J. L., W. Zhu, T. V. Golovkina, and S. R. Ross. Unpublished data.
7. Golovkina, T. V., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
8. Golovkina, T. V., A. Chervonsky, J. A. Prescott, C. A. Janeway, and S. R. Ross. 1994. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J. Exp. Med. 179:439-446.
9. Held, W., G. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. Robson-MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
10. Hilkens, J., B. van der Zeust, F. Buijs, V. Kroezen, N. Bluemink, and J. Hilgers. 1983. Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16. J. Virol. 45:140-147.
11. Howard, D. K., and J. Schlom. 1980. Isolation of a series of novel variants of murine mammary tumor viruses with broadened host range. Int. J. Cancer 25:647-654.
12. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
13. Michalides, R., L. van Deemter, R. Nusse, and R. van Nie. 1978. Identification of the Mtv-2 gene responsible for early appearance of mammary tumors in the GR mouse by nucleic acid hybridization. Proc. Natl. Acad. Sci. USA 75:2368-2372.
14. Nandi, S., and C. M. McGrath. 1973. Mammary neoplasia in mice. Adv. Cancer Res. 17:353-414.
15. Platt, E. J., and G. L. Firestone. 1991. Expression of mouse mammary tumor virus glycoprotein trucations defines roles for the transmembrane domain and ectodomain hydrophobic region in constitutive exocytic trafficking and proteolytic processing. J. Biol. Chem. 266:19384-19395.
16. Ross, S. R. 1996. MMTV and the immune system. Adv. Pharmacol. 37:21-46.
17. Ross, S. R., et al. Unpublished data.
18. Rowe, L. B., J. H. Nadeau, R. Turner, W. N. Frankel, V. A. Letts, J. T. Eppig, M. S. H. Ko, S. J. Thurston, and E. H. Birkenmeier. 1994. Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. Mamm. Genet. 5:253-274.
19. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T cell erythroeyte receptor by rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA 84:3365-3369.
20. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
21. Tsubura, A., M. Inaba, S. Imai, A. Murakami, N. Oyaizu, R. Yasumizu, Y. Ohnishi, H. Tanaka, S. Morii, and S. Ikehara. 1988. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo. Cancer Res. 48:6555-6559.
22. Waanders, G. A., A. N. Shakhov, W. Held, P. Karapetian, H. Acha-Orbea, and H. R. MacDonald. 1993. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J. Exp. Med. 177:1359-1366.
23. Weiss, R., N. Teich, H. Varmus, and J. Coffin. 1984. RNA tumor viruses, p. 590-591. In R. Weiss, N. Teich, and J. M. Coffin (ed.), Molecular biology of tumor viruses. CSH Press, Cold Spring Harbor, N.Y.
24. Weiss, R. A., and C. S. Tailor. 1995. Retrovirus receptors. Cell 82:531-533.
25. Zavada, J., C. Dickson, and R. Weiss. 1977. Pseudotypes of vesicular stomatitis virus with envelope antigens provided by murine mammary tumor virus. Virology 82:221-331.
26. Zingler, K., and J. A. T. Young. 1996. Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses. J. Virol. 70:7510-7516.